- Home
- AL vs GH Comparison
AL vs GH Comparison
Compare AL & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AL
- GH
- Stock Information
- Founded
- AL 2010
- GH 2011
- Country
- AL United States
- GH United States
- Employees
- AL N/A
- GH N/A
- Industry
- AL Diversified Commercial Services
- GH Medical Specialities
- Sector
- AL Consumer Discretionary
- GH Health Care
- Exchange
- AL Nasdaq
- GH Nasdaq
- Market Cap
- AL 4.7B
- GH 4.9B
- IPO Year
- AL 2011
- GH 2018
- Fundamental
- Price
- AL $57.52
- GH $46.46
- Analyst Decision
- AL Buy
- GH Strong Buy
- Analyst Count
- AL 5
- GH 20
- Target Price
- AL $61.40
- GH $54.35
- AVG Volume (30 Days)
- AL 654.8K
- GH 1.9M
- Earning Date
- AL 08-04-2025
- GH 07-30-2025
- Dividend Yield
- AL 1.53%
- GH N/A
- EPS Growth
- AL 15.59
- GH N/A
- EPS
- AL 5.72
- GH N/A
- Revenue
- AL $2,808,629,000.00
- GH $773,996,000.00
- Revenue This Year
- AL $10.00
- GH $23.37
- Revenue Next Year
- AL $7.18
- GH $21.31
- P/E Ratio
- AL $10.07
- GH N/A
- Revenue Growth
- AL 3.56
- GH 28.20
- 52 Week Low
- AL $38.25
- GH $20.14
- 52 Week High
- AL $60.41
- GH $53.42
- Technical
- Relative Strength Index (RSI)
- AL 48.28
- GH 39.77
- Support Level
- AL $57.31
- GH $48.90
- Resistance Level
- AL $58.94
- GH $49.30
- Average True Range (ATR)
- AL 1.09
- GH 1.83
- MACD
- AL -0.23
- GH -0.71
- Stochastic Oscillator
- AL 8.83
- GH 6.40
About AL Air Lease Corporation
Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in purchasing commercial jet aircrafts directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a majority of its revenue from the Asia-Pacific region and the rest from Europe, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.